Biologics Safety Testing Market Is Expected To Reach $8.2 Billion By 2028- An Exclusive Market Research Report By Lucintel

By Author: Lucintel LLC
Total Articles: 5674
Comment this article

Lucintel's latest market report analyzed that biologics safety testing provides attractive opportunities in vaccine development and manufacturing, monoclonal antibodies development and manufacturing, cellular & gene therapy product development and manufacturing, and blood and blood product development and manufacturing. The biologics safety testing market is expected to reach $8.2 billion by 2028 with a CAGR of 12.8%. In this market, residual host-cell proteins & DNA detection tests is the largest segment by type, whereas vaccine development and manufacturing is largest by application.
Download Brochure of this report by clicking on https://www.lucintel.com/biologics-safety-testing-market.aspx
Based on type, the biologics safety testing market is segmented into endotoxin test, sterility test, mycoplasma tests, bioburden tests, residual host-cell proteins & DNA detection tests, virus safety test, and other. The residual host-cell proteins & DNA detection tests segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, as ...
... it enables the biopharmaceutical manufacturers to demonstrate the safety and purity of their products before the regulatory authorities by testing for residual host cell proteins and DNA.
Browse in-depth TOC on “Biologics Safety Testing Market”
100 – Figures/Tables
150 – Pages
The Biologics Safety Testing Market is marked by the presence of several big and small players. Some of the prominent players offering biologics safety testing include Charles River Laboratories, Lonza, Thermo Fisher Scientific, Merck KGaA, and F. Hoffmann-La Roche.
Request Sample Report:
https://www.lucintel.com/biologics-safety-testing-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056

Related reports
Healthcare IT Market:
For more details click here https://www.lucintel.com/healthcare-it-market.aspx

Medical Holography Market:
For more details click here https://www.lucintel.com/medical-holography-market.aspx

Electrophysiology Market:
For more details click here https://www.lucintel.com/electrophysiology-market.aspx

Minimally Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

Endoscopy Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/elastomeric-foam-insulation-market.aspx

Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx

Industrial Microbiology Market:
For more details click here https://www.lucintel.com/opportunities-in-the-industrial-microbiologycolonopt-size,-trends-and-growth-analysis.aspx

Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx